A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
27461140
DOI
10.1016/j.jcf.2016.07.002
PII: S1569-1993(16)30559-8
Knihovny.cz E-zdroje
- Klíčová slova
- Cutoff, Cystic fibrosis, Immunoreactive trypsinogen, Newborn screening, Pancreatitis-associated protein,
- MeSH
- chemické techniky analytické MeSH
- cystická fibróza * krev diagnóza MeSH
- lidé MeSH
- novorozenec MeSH
- novorozenecký screening metody MeSH
- proteiny asociované s pankreatitidou analýza MeSH
- retrospektivní studie MeSH
- senzitivita a specificita MeSH
- trypsinogen * analýza imunologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- proteiny asociované s pankreatitidou MeSH
- trypsinogen * MeSH
BACKGROUND: In cystic fibrosis newborn screening (CFNBS), immunoreactive trypsinogen (IRT) and pancreatitis-associated protein (PAP) can be used as screening parameters. We evaluated the IRT×PAP product as second-tier parameter in CFNBS in newborns with elevated IRT. METHODS: Data on 410,111 screened newborns including 78 patients with classical cystic fibrosis (CF) from two European centers were retrospectively analyzed by discrimination analysis to identify a screening protocol with optimal cutoffs. We also studied differences in PAP measurement methods and the association of IRT and PAP with age. RESULTS: PAP values differed systematically between fluorometric and photometric assays. The IRT×PAP product showed better discrimination for classical CF than PAP only as second-tier screening parameter (p<0.001). In CF patients, IRT decreased while PAP values remained high over years. In newborns without CF, IRT decreased after birth over weeks while PAP increased within days. CONCLUSIONS: The IRT×PAP product performs well as second-tier cutoff parameter for CFNBS. Screening quality parameters depend on the analytic method and on age at blood collection.
Citace poskytuje Crossref.org